PE anti-human CD197 (CCR7) [G043H7] and 2 more items

BIOLEGEND INC. has been awarded contract A207_PO-0463511-V2 by the University of Virginia, a contracting organization located in Virginia, effective October 12, 2026. The contract encompasses the delivery of specialized flow cytometry reagents and antibodies totaling $602. The deliverables consist of three distinct line items: one unit of PE anti-human CD197 (CCR7) [G043H7] antibody priced at $81.90; two units of PE/Cyanine7 anti-mouse CD45.1 [A20] antibody at $146.30 each; and one unit of Brilliant Violet 650 anti-mouse CD45.2 [104] antibody priced at $228.00. All items are designated for delivery to Kara L Cummings at the University of Virginia.

These reagents are fluorescently-labeled monoclonal antibodies used in immunological research and flow cytometric analysis. The contract represents a research supply purchase for laboratory applications at the University of Virginia. As a purchasing order rather than a comprehensive service contract, the engagement involves product procurement without a defined long-term performance period beyond the award date of October 12, 2026.